Chen Xi, Kong Xiaohong, Zhu Jie, Zhang Tingting, Li Yanwei, Ding Guifeng, Wang Huijuan
Center for Genetic & Metabolic Disorders, Maternal and Child Health Care Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
The National Engineering Research Center for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi'an, China.
Int J Endocrinol. 2018 Aug 2;2018:8986475. doi: 10.1155/2018/8986475. eCollection 2018.
Thyroid dyshormonogenesis (DH) is a genetically heterogeneous inherited disorder caused by thyroid hormone synthesis abnormalities. This study aims at comprehensively characterizing the mutation spectrum in Chinese patients with DH.
We utilized next-generation sequencing to screen for mutations in seven DH-associated genes (TPO, DUOX2, TG, DUOXA2, SLC26A4, SLC5A5, and IYD) in 21 Chinese Han patients with DH from Xinjiang Province.
Twenty-eight rare nonpolymorphic variants were found in 19 patients (90.5%), including 19, 5, 3, and 1 variants in DUOX2, TG, DUOXA2, and SLC26A4, respectively. Thirteen (62%) patients carried monogenic mutations, and six (28.5%) carried oligogenic mutations. Fifteen (71%) patients carried 2 or more DUOX2 (14) or DUOXA2 (1) variants. The genetic basis of DH in nine (43%) patients harboring biallelic or triallelic pathogenic variants was resolved. Seventeen patients (81%) carried DUOX2 mutations, most commonly p.R1110Q or p.K530X. No correlations were found between DUOX2 mutation types or numbers and clinical phenotypes.
DUOX2 mutations were the most predominant genetic alterations of DH in the study cohort. Oligogenicity may explain the genetic basis of disease in many DH patients. Functional studies and further clinical studies with larger DH patient cohorts are needed to validate the roles of the mutations identified in this study.
甲状腺激素合成障碍(DH)是一种由甲状腺激素合成异常引起的遗传异质性遗传性疾病。本研究旨在全面描述中国DH患者的突变谱。
我们利用二代测序技术对来自新疆的21例中国汉族DH患者的7个与DH相关的基因(TPO、DUOX2、TG、DUOXA2、SLC26A4、SLC5A5和IYD)进行突变筛查。
在19例患者(90.5%)中发现了28个罕见的非多态性变异,其中DUOX2、TG、DUOXA2和SLC26A4分别有19、5、3和1个变异。13例(62%)患者携带单基因突变,6例(28.5%)携带寡基因突变。15例(71%)患者携带2个或更多的DUOX2(14例)或DUOXA2(1例)变异。9例(43%)携带双等位基因或三等位基因致病变异的患者的DH遗传基础得以明确。17例(81%)患者携带DUOX2突变,最常见的是p.R1110Q或p.K530X。未发现DUOX2突变类型或数量与临床表型之间存在相关性。
DUOX2突变是本研究队列中DH最主要的遗传改变。寡基因性可能解释了许多DH患者的疾病遗传基础。需要进行功能研究以及对更大的DH患者队列进行进一步的临床研究,以验证本研究中鉴定出的突变的作用。